Conserved regulators of Rag GTPases orchestrate amino acid-dependent TORC1 signaling

Cell Discovery

Volumn 2, Issue , 2016, Pages

  Powis, Katie ^a   De Virgilio, Claudio ^a  

^a UNIVERSITY OF FRIBOURG   (Switzerland)

Author keywords

amino acid signaling; Rag GTPases; target of rapamycin complex 1

Indexed keywords

GATOR1 PROTEIN; GUANOSINE TRIPHOSPHATASE; PROTEIN; RAS RELATED GTP BINDING PROTEIN; TARGET OF RAPAMYCIN COMPLEX 1; TARGET OF RAPAMYCIN KINASE; TERNARY COMPLEX FACTOR; UNCLASSIFIED DRUG; VAM6 PROTEIN;

GENETIC CONSERVATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION;

EID: 84974697861     PISSN: None     EISSN: 20565968     Source Type: Journal    
DOI: 10.1038/celldisc.2015.49     Document Type: Review

References (117)

1. Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell 2012; 149: 274-293.
2. Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell 2006; 124: 471-484.
3. Peterson TR, Laplante M, Thoreen CC et al. DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell 2009; 137: 873-886.
4. Sancak Y, Thoreen CC, Peterson TR et al. PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol Cell 2007; 25: 903-915.
5. Sancak Y, Peterson TR, Shaul YD et al. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 2008; 320: 1496-1501.
6. Hara K, Yonezawa K, Weng QP, Kozlowski MT, Belham C, Avruch J. Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. J Biol Chem 1998; 273: 14484-14494.
7. Wang X, Campbell LE, Miller CM, Proud CG. Amino acid availability regulates p70 S6 kinase and multiple translation factors. Biochem J 1998; 334: 261-267.
8. Crespo JL, Powers T, Fowler B, Hall MN. The TORcontrolled transcription activators GLN3, RTG1, and RTG3 are regulated in response to intracellular levels of glutamine. Proc Natl Acad Sci 2002; 99: 6784-6789.
9. Yao K, Yin YL, Chu W et al. Dietary arginine supplementation increases mTOR signaling activity in skeletal muscle of neonatal pigs. J Nutr 2008; 138: 867-872.
10. Kong X, Tan B, Yin Y et al. L-Arginine stimulates the mTOR signaling pathway and protein synthesis in porcine trophectoderm cells. J Nutr Biochem 2012; 23: 1178-1183.
11. Yang H, Gong R, Xu Y. Control of cell growth: Rag GTPases in activation of TORC1. Cell Mol Life Sci 2013; 70: 2873-2885.
12. Gong R, Li L, Liu Y et al. Crystal structure of the Gtr1p-Gtr2p complex reveals new insights into the amino acidinduced TORC1 activation. Genes Dev 2011; 25: 1668-1673.
13. Sekiguchi T, Hirose E, Nakashima N, Ii M, Nishimoto T. Novel G proteins, Rag C and Rag D, interact with GTPbinding proteins, Rag A and Rag B. J Biol Chem 2001; 276: 7246-7257.
14. Nakashima N, Noguchi E, Nishimoto T. Saccharomyces cerevisiae putative G protein, Gtr1p, which forms complexes with itself and a novel protein designated as Gtr2p, negatively regulates the Ran/Gsp1p G protein cycle through Gtr2p. Genetics 1999; 152: 853-867.
15. Binda M, Péli-Gulli MP, Bonfils G et al. The Vam6 GEF controls TORC1 by activating the EGO complex. Mol Cell 2009; 35: 563-573.
16. Gao M, Kaiser CA. A conserved GTPase-containing complex is required for intracellular sorting of the general amino-acid permease in yeast. Nat Cell Biol 2006; 8: 657-667.
17. Kim E, Goraksha-Hicks P, Li L, Neufeld TP, Guan KL. Regulation of TORC1 by Rag GTPases in nutrient response. Nat Cell Biol 2008; 10: 935-945.
18. Fawal MA, Brandt M, Djouder N. MCRS1 binds and couples Rheb to amino acid-dependent mTORC1 activation. Dev Cell 2015; 33: 67-81.
19. Demetriades C, Doumpas N, Teleman AA. Regulation of TORC1 in response to amino acid starvation via lysosomal recruitment of TSC2. Cell 2014; 156: 786-799.
20. Averous J, Lambert-Langlais S, Carraro V et al. Requirement for lysosomal localization of mTOR for its activation differs between leucine and other amino acids. Cell Signal 2014; 26: 1918-1927.
21. Dibble CC, Elis W, Menon S et al. TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1. Mol Cell 2012; 47: 535-546.
22. Inoki K, Li Y, Xu T, Guan KL. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev 2003; 17: 1829-1834.
23. Tee AR, Manning BD, Roux PP, Cantley LC, Blenis J. Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPaseactivating protein complex toward Rheb. Curr Biol 2003; 13: 1259-1268.
24. Menon S, Dibble CC, Talbott G et al. Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome. Cell 2014; 156: 771-785.
25. Kira S, Tabata K, Shirahama-Noda K, Nozoe A, Yoshimori T, Noda T. Reciprocal conversion of Gtr1 and Gtr2 nucleotide-binding states by Npr2-Npr3 inactivates TORC1 and induces autophagy. Autophagy 2014; 10: 1565-1578.
26. GDP protein complex reveals large structural rearrangements triggered by GTP-to-GDP conversion. J Biol Chem 2012; 287: 29648-29653.
27. Tsun ZY, Bar-Peled L, Chantranupong L et al. The folliculin tumor suppressor is a GAP for the RagC/D GTPases that signal amino acid levels to mTORC1. Mol Cell 2013; 52: 495-505.
28. Dubouloz F, Deloche O, Wanke V, Cameroni E, De Virgilio C. The TOR and EGO protein complexes orchestrate microautophagy in yeast. Mol Cell 2005; 19: 15-26.
29. Zhang T, Péli-Gulli MP, Yang H, De Virgilio C, Ding J. Ego3 functions as a homodimer to mediate the interaction between Gtr1-Gtr2 and Ego1 in the EGO complex to activate TORC1. Structure 2012; 20: 2151-2160.
30. Powis K, Zhang T, Panchaud N, Wang R, De Virgilio C, Ding J. Crystal structure of the Ego1-Ego2-Ego3 complex and its role in promoting Rag GTPase-dependent TORC1 signaling. Cell Res 2015; 25: 1043-1059.
31. Ashrafi K, Farazi TA, Gordon JI. A role for Saccharomyces cerevisiae fatty acid activation protein 4 in regulating protein N-myristoylation during entry into stationary phase. J Biol Chem 1998; 273: 25864-25874.
32. Nadolski MJ, Linder ME. Molecular recognition of the palmitoylation substrate Vac8 by its palmitoyltransferase Pfa3. J Biol Chem 2009; 284: 17720-17730.
33. Roth AF, Wan J, Bailey AO et al. Global analysis of protein palmitoylation in yeast. Cell 2006; 125: 1003-1013.
34. Kogan K, Spear ED, Kaiser CA, Fass D. Structural conservation of components in the amino acid sensing branch of the TOR pathway in yeast and mammals. J Mol Biol 2010; 402: 388-398.
35. Levine TP, Daniels RD, Wong LH, Gatta AT, Gerondopoulos A, Barr FA. Discovery of new Longin and Roadblock domains that form platforms for small GTPases in Ragulator and TRAPP-II. Small GTPases 2013; 4: 62-69.
36. Bar-Peled L, Schweitzer LD, Zoncu R, Sabatini DM. Ragulator is a GEF for the rag GTPases that signal amino acid levels to mTORC1. Cell 2012; 150: 1196-1208.
37. Sancak Y, Bar-Peled L, Zoncu R, Markhard AL, Nada S, Sabatini DM. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 2010; 141: 290-303.
38. Nada S, Hondo A, Kasai A et al. The novel lipid raft adaptor p18 controls endosome dynamics by anchoring the MEK-ERK pathway to late endosomes. EMBO J 2009; 28: 477-489.
39. +-ATPase. Science 2011; 334: 678-683.
40. +-ATPase assembly. J Biol Chem 2015; 290: 27360-27369.
41. Zhang CS, Jiang B, Li M et al. The lysosomal v-ATPase-Ragulator complex is a common activator for AMPK and mTORC1, acting as a switch between catabolism and anabolism. Cell Metab 2014; 20: 526-540.
42. Krogan NJ, Cagney G, Yu H et al. Global landscape of protein complexes in the yeast Saccharomyces cerevisiae. Nature 2006; 440: 637-643.
43. Tarassov K, Messier V, Landry CR et al. An in vivo map of the yeast protein interactome. Science 2008; 320: 1465-1470.
44. Dechant R, Saad S, Ibanez AJ, Peter M. Cytosolic pH regulates cell growth through distinct GTPases, Arf1 and Gtr1, to promote Ras/PKA and TORC1 activity. Mol Cell 2014; 55: 409-421.
45. Dechant R, Binda M, Lee SS, Pelet S, Winderickx J, Peter M. Cytosolic pH is a second messenger for glucose and regulates the PKA pathway through V-ATPase. EMBO J 2010; 29: 2515-2526.
46. Starai VJ, Hickey CM, Wickner W. HOPS proofreads the trans-SNARE complex for yeast vacuole fusion. Mol Biol Cell 2008; 19: 2500-2508.
47. Price A, Wickner W, Ungermann C. Proteins needed for vesicle budding from the golgi complex are also required for the docking step of homotypic vacuole fusion. J Cell Biol 2000; 148: 1223-1229.
48. Kümmel D, Ungermann C. Principles of membrane tethering and fusion in endosome and lysosome biogenesis. Curr Opin Cell Biol 2014; 29: 61-66.
49. Valbuena N, Guan KL, Moreno S. The Vam6 and Gtr1-Gtr2 pathway activates TORC1 in response to amino acids in fission yeast. J Cell Sci 2012; 125: 1920-1928.
50. Zurita-Martinez SA, Puria R, Pan X, Boeke JD, Cardenas ME. Efficient Tor signaling requires a functional class C Vps protein complex in Saccharomyces cerevisiae. Genetics 2007; 176: 2139-2150.
51. Kingsbury JM, Sen ND, Maeda T, Heitman J, Cardenas ME. Endolysosomal membrane trafficking complexes drive nutrient-dependent TORC1 signaling to control cell growth in Saccharomyces cerevisiae. Genetics 2014; 196: 1077-1089.
52. Elbaz-Alon Y, Rosenfeld-Gur E, Shinder V, Futerman AH, Geiger T, Schuldiner M. A dynamic interface between vacuoles and mitochondria in yeast. Dev Cell 2014; 30: 95-102.
53. Hönscher C, Mari M, Auffarth K et al. Cellular metabolism regulates contact sites between vacuoles and mitochondria. Dev Cell 2014; 30: 86-94.
54. Flinn RJ, Yan Y, Goswami S, Parker PJ, Backer JM. The late endosome is essential for mTORC1 signaling. Mol Biol Cell 2010; 21: 833-841.
55. Lachmann J, Glaubke E, Moore P, Ungermann C. The Vps39-like TRAP1 is an effector of Rab5 and likely the missing Vps3 subunit of human CORVET. Cell Logist 2014; 4: e970840.
56. Avruch J, Long X, Ortiz-Vega S, Rapley J, Papageorgiou A, Dai N. Amino acid regulation of TOR complex 1. Am J Physiol Endocrinol Metab 2009; 296: E592-E602.
57. Bonfils G, Jaquenoud M, Bontron S, Ostrowicz C, Ungermann C, De Virgilio C. Leucyl-tRNA synthetase controls TORC1 via the EGO complex. Mol Cell 2012; 46: 105-110.
58. Han JM, Jeong SJ, Park MC et al. Leucyl-tRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathway. Cell 2012; 149: 410-424.
59. Leu in the post-transfer-editing conformation. Nat Struct Mol Biol 2005; 12: 923-930.
60. Petit CS, Roczniak-Ferguson A, Ferguson SM. Recruitment of folliculin to lysosomes supports the amino aciddependent activation of Rag GTPases. J Cell Biol 2013; 202: 1107-1122.
61. Martina JA, Diab HI, Lishu L et al. The nutrientresponsive transcription factor TFE3 promotes autophagy, lysosomal biogenesis, and clearance of cellular debris. Sci Signal 2014; 7: ra9.
62. Péli-Gulli MP, Sardu A, Panchaud N, Raucci S, De Virgilio C. Amino acids stimulate TORC1 through Lst4-Lst7, a GTPase-activating protein complex for the Rag family GTPase Gtr2. Cell Rep 2015; 13: 1-7.
63. Nickerson ML, Warren MB, Toro JR et al. Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome. Cancer Cell 2002; 2: 157-164.
64. Baba M, Furihata M, Hong SB et al. Kidney-targeted Birt-Hogg-Dubé gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys. J Natl Cancer Inst 2008; 100: 140-154.
65. Birt AR, Hogg GR, Dubé WJ. Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons. Arch Dermatol 1977; 113: 1674-1677.
66. Hasumi Y, Baba M, Ajima R et al. Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2. Proc Natl Acad Sci 2009; 106: 18722-18727.
67. Neklesa TK, Davis RW. A genome-wide screen for regulators of TORC1 in response to amino acid starvation reveals a conserved Npr2/3 complex. PLoS Genet 2009; 5: e1000515.
68. Bar-Peled L, Chantranupong L, Cherniack AD et al. A tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1. Science 2013; 340: 1100-1106.
69. Panchaud N, Péli-Gulli MP, De Virgilio C. Amino acid deprivation inhibits TORC1 through a GTPase-activating protein complex for the Rag family GTPase Gtr1. Sci Signal 2013; 6: ra42.
70. Panchaud N, Péli-Gulli MP, De Virgilio C. SEACing the GAP that nEGOCiates TORC1 activation: evolutionary conservation of Rag GTPase regulation. Cell Cycle 2013; 12: 2948-2952.
71. Sutter BM, Wu X, Laxman S, Tu BP. Methionine inhibits autophagy and promotes growth by inducing the SAM-responsive methylation of PP2A. Cell 2013; 154: 403-415.
72. Dokudovskaya S, Rout MP. SEA you later alli-GATOR - a dynamic regulator of the TORC1 stress response pathway. J Cell Sci 2015; 128: 2219-2228.
73. Deng L, Jiang C, Chen L et al. The ubiquitination of RagA GTPase by RNF152 negatively regulates mTORC1 activation. Mol Cell 2015; 58: 804-818.
74. Jin G, Lee SW, Zhang X et al. Skp2-mediated RagA ubiquitination elicits a negative feedback to prevent aminoacid-dependent mTORC1 hyperactivation by recruiting GATOR1. Mol Cell 2015; 58: 989-1000.
75. Stracka D, Jozefczuk S, Rudroff F, Sauer U, Hall MN. Nitrogen source activates TOR (target of rapamycin) complex 1 via glutamine and independently of Gtr/Rag proteins. J Biol Chem 2014; 289: 25010-25020.
76. Peng M, Yin N, Li MO. Sestrins function as guanine nucleotide dissociation inhibitors for Rag GTPases to control mTORC1 signaling. Cell 2014; 159: 122-133.
77. Parmigiani A, Nourbakhsh A, Ding B et al. Sestrins inhibit mTORC1 kinase activation through the GATOR complex. Cell Rep 2014; 9: 1281-1291.
78. Chantranupong L, Wolfson RL, Orozco JM et al. The Sestrins interact with GATOR2 to negatively regulate the amino-acid-sensing pathway upstream of mTORC1. Cell Rep 2014; 9: 1-8.
79. Kim JS, Ro SH, Kim M et al. Sestrin2 inhibits mTORC1 through modulation of GATOR complexes. Sci Rep 2015; 5: 9502.
80. Lee JH, Budanov AV, Park EJ et al. Sestrin as a feedback inhibitor of TOR that prevents age-related pathologies. Science 2010; 327: 1223-1228.
81. Budanov AV, Karin M. p53 target genes Sestrin1 and Sestrin2 connect genotoxic stress and mTOR signaling. Cell 2008; 134: 451-460.
82. Wolfson RL, Chantranupong L, Saxton RA et al. Sestrin2 is a leucine sensor for the mTOR pathway. Science pii:aab2674 (e-pub ahead of print 8 October 2015; doi: 10.1126/science.aab2674).
83. Saxton RA, Knockenhauer KE, Wolfson RL et al. Structural basis for leucine sensing by the Sestrin2-mTORC1 pathway. Science pii:aab2087 (e-pub ahead of print 19 November 2015; doi: 10.1126/science.aab2087).
84. Lee JH, Budanov AV, Karin M. Sestrins orchestrate cellular metabolism to attenuate aging. Cell Metab 2013; 18: 792-801.
85. Wang S, Tsun ZY, Wolfson RL et al. Metabolism. Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1. Science 2015; 347: 188-194.
86. Rebsamen M, Pochini L, Stasyk T et al. SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1. Nature 2015; 519: 477-481.
87. Jung J, Genau HM, Behrends C. Amino acid-dependent mTORC1 regulation by the lysosomal membrane protein SLC38A9. Mol Cell Biol 2015; 35: 2479-2494.
88. Thwaites DT, Anderson CM. The SLC36 family of protoncoupled amino acid transporters and their potential role in drug transport. Br J Pharmacol 2011; 164: 1802-1816.
89. Ögmundsdóttir MH, Heublein S, Kazi S et al. Protonassisted amino acid transporter PAT1 complexes with Rag GTPases and activates TORC1 on late endosomal and lysosomal membranes. PLoS ONE 2012; 7: e36616.
90. Kobayashi T, Shimabukuro-Demoto S, Yoshida-Sugitani R et al. The histidine transporter SLC15A4 coordinates mTOR-dependent inflammatory responses and pathogenic antibody production. Immunity 2014; 41: 375-388.
91. Ljungdahl PO, Daignan-Fornier B. Regulation of amino acid, nucleotide, and phosphate metabolism in Saccharomyces cerevisiae. Genetics 2012; 190: 885-929.
92. Yang Z, Huang J, Geng J, Nair U, Klionsky DJ. Atg22 recycles amino acids to link the degradative and recycling functions of autophagy. Mol Biol Cell 2006; 17: 5094-5104.
93. Russnak R, Konczal D, McIntire SL. A family of yeast proteins mediating bidirectional vacuolar amino acid transport. J Biol Chem 2001; 276: 23849-23857.
94. Bryk B, Hahn K, Cohen SM, Teleman AA. MAP4K3 regulates body size and metabolism in Drosophila. Dev Biol 2010; 344: 150-157.
95. Findlay GM, Yan L, Procter J, Mieulet V, Lamb RF. A MAP4 kinase related to Ste20 is a nutrient-sensitive regulator of mTOR signalling. Biochem J 2007; 403: 13-20.
96. T61∈ is an inhibitor of MAP4K3 in nutrient signaling to mTOR. Mol Cell 2010; 37: 633-642.
97. Duran A, Amanchy R, Linares JF et al. p62 is a key regulator of nutrient sensing in the mTORC1 pathway. Mol Cell 2011; 44: 134-146.
98. Kim YM, Stone M, Hwang TH et al. SH3BP4 is a negative regulator of amino acid-Rag GTPase-mTORC1 signaling. Mol Cell 2012; 46: 833-846.
99. Schweitzer LD, Comb WC, Bar-Peled L, Sabatini DM. Disruption of the Rag-Ragulator complex by c17orf59 inhibits mTORC1. Cell Rep 2015; 12: 1445-1455.
100. Durán RV, Oppliger W, Robitaille AM et al. Glutaminolysis activates Rag-mTORC1 signaling. Mol Cell 2012; 47: 349-358.
101. Jewell JL, Kim YC, Russell RC et al. Differential regulation of mTORC1 by leucine and glutamine. Science 2015; 347: 194-198.
102. Thomas JD, Zhang YJ, Wei YH et al. Rab1A is an mTORC1 activator and a colorectal oncogene. Cancer Cell 2014; 26: 754-769.
103. Oshiro N, Rapley J, Avruch J. Amino acids activate mammalian target of rapamycin (mTOR) complex 1 without changing Rag GTPase guanyl nucleotide charging. J Biol Chem 2014; 289: 2658-2674.
104. Bohn G, Allroth A, Brandes G et al. A novel human primary immunodeficiency syndrome caused by deficiency of the endosomal adaptor protein p14. Nat Med 2007; 13: 38-45.
105. Tang Y, Jiang L, Tang W. Decreased expression of NPRL2 in renal cancer cells is associated with unfavourable pathological, proliferation and apoptotic features. Pathol Oncol Res 2014; 20: 829-837.
106. Ueda K, Kawashima H, Ohtani S et al. The 3p21.3 tumor suppressor NPRL2 plays an important role in cisplatininduced resistance in human non-small-cell lung cancer cells. Cancer Res 2006; 66: 9682-9690.
107. Ji L, Nishizaki M, Gao BN et al. Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo. Cancer Res 2002; 62: 2715-2720.
108. Li J, Wang F, Haraldson K et al. Functional characterization of the candidate tumor suppressor gene NPRL2/G21 located in 3p21.3C. Cancer Res 2004; 64: 6438-6443.
109. Anedchenko EA, Dmitriev AA, Krasnov GS et al. Downregulation of RBSP3/CTDSPL, NPRL2/G21, RASSF1A, ITGA9, HYAL1, and HYAL2 in non-small cell lung cancer. Mol Biol 2008; 42: 859-869.
110. Otani S, Takeda S, Yamada S et al. The tumor suppressor NPRL2 in hepatocellular carcinoma plays an important role in progression and can be served as an independent prognostic factor. J Surg Oncol 2009; 100: 358-363.
111. Dibbens LM, de Vries B, Donatello S et al. Mutations in DEPDC5 cause familial focal epilepsy862 with variable foci. Nat Genet 2013; 45: 546-551.
112. Ishida S, Picard F, Rudolf G et al. Mutations of DEPDC5 cause autosomal dominant focal epilepsies. Nat Genet 2013; 45: 552-555.
113. Picard F, Makrythanasis P, Navarro V et al. DEPDC5 mutations in families presenting as autosomal dominant nocturnal frontal lobe epilepsy. Neurology 2014; 82: 2101-2106.
114. Scheffer IE, Heron SE, Regan BM et al. Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations. Ann Neurol 2014; 75: 782-787.
115. Lal D, Reinthaler EM, Schubert J et al. DEPDC5 mutations in genetic focal epilepsies of childhood. Ann Neurol 2014; 75: 788-792.
116. Martin C, Meloche C, Rioux MF et al. A recurrent mutation in DEPDC5 predisposes to focal epilepsies in the French-Canadian population. Clin Genet 2014; 86: 570-574.
117. Efeyan A, Zoncu R, Chang S et al. Regulation of mTORC1 by the Rag GTPases is necessary for neonatal autophagy and survival. Nature 2013; 493: 679-683.